Table 1.
Baseline Characteristics of Subjects (n=280)
| Characteristic | Value |
|---|---|
| Clinical | |
| Age, yr | 51±11 |
| Male sex | 157 (56.1) |
| DM | 18 (6.7) |
| Systolic BP, mm Hg | 124.29±14.67 |
| Diastolic BP, mm Hg | 77.7±9.75 |
| CAP, dB/m | 245.91±47.86 |
| Stiffness, kPa | 4.59±2.84 |
| HBsAg positive | 13 (4.6) |
| Anti-HCV positive | 1 (0.4) |
| Anthropometric | |
| BMI, kg/m2 | 23.90±3.03 |
| Body fat rate, % | 25.73±5.46 |
| Visceral fat grade, 1–24 | 10.19±3.37 |
| Visceral fat area, cm2 | 94.81±41.02 |
| Visceral fat, kg | 2.33±1.75 |
| Subcutaneous fat, kg | 14.54±3.80 |
| Biochemical | |
| AST, IU/L | 24.91±12.02 |
| ALT, IU/L | 27.43±24.98 |
| GGT, IU/L | 37.80±56.71 |
| Fasting glucose, mg/dL | 100.89±15.97 |
| Total cholesterol, mg/dL | 200.26±37.68 |
| Triglyceride, mg/dL | 121.15±72.69 |
| HDL, mg/dL | 51.34±12.90 |
| LDL, mg/dL | 121.69±31.65 |
Data are presented as mean±SD or number (%).
DM, diabetes mellitus; BP, blood pressure; CAP, controlled attenuation parameter; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ-glutamyltranspeptidase; HDL, high-density lipoprotein; LDL, low-density lipoprotein.